IL6 and Duchenne muscular dystrophy: The anti‐inflammatory effect of HCAR2 was previously demonstrated in several models including DMD primary myoblasts involving IL‐6, in the mdx mouse, and in macrophages via nicotinic acid and NFκB suppression [23, 24, 25].